- Home
- GHI vs PGEN Comparison
GHI vs PGEN Comparison
Compare GHI & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHI
- PGEN
- Stock Information
- Founded
- GHI 1998
- PGEN 1998
- Country
- GHI United States
- PGEN United States
- Employees
- GHI N/A
- PGEN N/A
- Industry
- GHI Finance: Consumer Services
- PGEN Biotechnology: Pharmaceutical Preparations
- Sector
- GHI Finance
- PGEN Health Care
- Exchange
- GHI Nasdaq
- PGEN Nasdaq
- Market Cap
- GHI 287.2M
- PGEN 292.6M
- IPO Year
- GHI N/A
- PGEN N/A
- Fundamental
- Price
- GHI $10.75
- PGEN $0.68
- Analyst Decision
- GHI Strong Buy
- PGEN Buy
- Analyst Count
- GHI 4
- PGEN 5
- Target Price
- GHI $17.50
- PGEN $7.00
- AVG Volume (30 Days)
- GHI 97.5K
- PGEN 929.1K
- Earning Date
- GHI 11-06-2024
- PGEN 11-14-2024
- Dividend Yield
- GHI 13.71%
- PGEN N/A
- EPS Growth
- GHI N/A
- PGEN N/A
- EPS
- GHI 0.61
- PGEN N/A
- Revenue
- GHI $34,307,528.00
- PGEN $3,963,000.00
- Revenue This Year
- GHI N/A
- PGEN N/A
- Revenue Next Year
- GHI $10.35
- PGEN $426.76
- P/E Ratio
- GHI $17.60
- PGEN N/A
- Revenue Growth
- GHI 28.98
- PGEN N/A
- 52 Week Low
- GHI $10.67
- PGEN $0.67
- 52 Week High
- GHI $17.48
- PGEN $1.93
- Technical
- Relative Strength Index (RSI)
- GHI 30.18
- PGEN 31.82
- Support Level
- GHI $10.77
- PGEN $0.76
- Resistance Level
- GHI $11.53
- PGEN $0.83
- Average True Range (ATR)
- GHI 0.31
- PGEN 0.06
- MACD
- GHI -0.02
- PGEN -0.02
- Stochastic Oscillator
- GHI 5.63
- PGEN 1.83
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.